Suppressing ADCK2 profoundly inhibited NSCLC cell viability, proliferation, and motility, disrupted essential mitochondrial functions, and weakened Akt-mTOR signaling, ultimately curbing tumor growth [33]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.